The Influenza‐Specific Immunoglobulin Repertoire – Nimble Yet Steeped in Tradition
Open Access
- 25 August 2026
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 341 (1) , e70164
Abstract
Influenza virus has circulated in the human population and co‐evolved with us for centuries or longer, shaping our immune repertoires through a continuous host–virus arms race. Across individuals, antibodies repeatedly converge on shared solutions for capturing this shape‐shifting virus by precisely targeting conserved sites of vulnerability—sites the virus cannot alter without functional cost—through structural features encoded directly by germline immunoglobulin genes. These recurring public antibodies, termed multi‐donor class antibodies, have been pivotal for understanding human anti‐influenza immunity and in guiding vaccine strategies that may shift the balance of the host–virus arms race. As single‐cell biology, structural biology, and computational approaches mature, previously uncharted areas of our immune repertoires are coming into view. Here, we review the current understanding of the influenza‐specific immune repertoire, focusing on antibodies and multi‐donor antibody classes directed toward antigenic supersites on viral hemagglutinin and neuraminidase—the two major targets of protective antibodies—and discuss how these insights may advance the development of game‐changing influenza vaccines.Keywords
Funding Information
- National Institutes of Health
This publication has 108 references indexed in Scilit:
- Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaquesCell, 2024
- Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of HumansCell Reports, 2019
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceCell, 2019
- Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive AntibodiesCell, 2018
- Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA StemCell Reports, 2017
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesCell, 2016
- Structure and Function Analysis of an Antibody Recognizing All Influenza A SubtypesCell, 2016
- Viral Receptor-Binding Site Antibodies with Diverse Germline OriginsCell, 2015
- Studies of the Binding Properties of Influenza Hemagglutinin Receptor-Site MutantsVirology, 1998
- Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodiesVirology, 1984